ArticleBiochimica et biophysica acta. Molecular and cell biology of lipids2026
Intestinal stearoyl-CoA desaturase-2 is highly expressed and nutritionally regulated but dispensable for energy balance.
Article in Biochimica et biophysica acta. Molecular and cell biology of lipids, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The stearoyl-CoA desaturase (SCD) enzymes convert saturated fatty acids to monounsaturated fatty acids (MUFAs). Deletion of intestinal SCD1 confers metabolic benefits upon high-fat diet (HFD) feeding. We report here that mice express a second SCD isoform in the intestine. SCD2 is expressed at much greater levels than SCD1 along the small intestine and colon. SCD2 displays spatial enrichment in the distal small intestine and in the colon and nutritional regulation by dietary fat and sucrose. Deletion of intestinal SCD2 (in 2iKO mice) reduces colonic, hepatic, and plasma triglycerides. However, MUFA levels and desaturation ratios are largely unimpacted in 2iKO intestines. SCD2 deletion is accompanied by upregulation of SCD1 and the fatty acid transporter, CD36, which together may help retain MUFA balance in the gut. Consistent with a lack of impact on MUFA levels, deletion of SCD2 does not protect mice from HFD-induced metabolic dysfunction. However, upon sucrose refeeding, SCD2 deletion blunts hepatic lipogenesis and triglyceride accumulation, suggesting that intestinal SCD2 modulates interorgan communication under conditions of carbohydrate overfeeding. While SCD1 and CD36 likely help retain MUFA balance in 2iKO mice intestines, primary organoids cultured ex vivo indicate significant reductions in overall desaturase activity in 2iKO organoids, despite increases in Scd1 expression. 2iKO organoids do not, however, induce Cd36 expression, and this is accompanied by a significant induction of ER stress in 2iKO organoids. Together, these data reveal a novel role for intestinal SCD2 in maintaining cellular MUFA balance to modulate responses to nutrient overload and to prevent ER stress.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.